Context Therapeutics (CNTX) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 24, 2026, with voting open until June 23, 2026, at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies by June 10, 2026.

Voting matters and shareholder proposals

• Election of seven director nominees to serve until the 2027 Annual Meeting.

• Ratification of CohnReznick LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Approval sought to amend the Certificate of Incorporation to increase authorized common stock from 200,000,000 to 300,000,000.

• Proposal to approve adjournment of the meeting if more time is needed to solicit votes for the share increase.

Board of directors and corporate governance

• Seven director nominees listed: Philip Kantoff, MD; Martin Lehr; Andy Pasternak; Karen Smith, MD; Jennifer Evans Stacey; Luke Walker, MD; Linda West.